Skip to main content
← Science / Explained

SERIES: MYTHS READ AGAINST THE SCIENCE

No clear mechanism ties GLP-1 to lower libido

The Signal

There is no clear mechanism in the literature that says the peptide lowers libido. The signal has not been studied directly in a trial.

The Overlapping Factors

Libido is shaped by sleep, stress, hormones, body composition, body image, relationship context, other medications, and nutrition. Each of those moves during weight loss. Some shifts (lower visceral fat, better sleep, improved insulin signaling) tend to favor libido. Others (under-eating, micronutrient gaps, fatigue) push the other way.

The Nearest Evidence

A 2024 systematic review on GLP-1 and reward-system pathways found the peptides affect motivation and craving, but the review covered food and substance use, not sexual function specifically.

What this means

References1 sources

How to read these sources

This article uses primary sources and reviews to separate mechanism, human evidence, and context.

ReviewExpert synthesis
Show 4 more source types
Official LabelRegulator documents
Human TrialStudies in people
MechanismCell and pathway logic
Public UpdateNews or announcements
  1. Review

    Physiology & Behavior

    Elsevier

    Badulescu, S., et al. · 2024 Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review Read source

    Used Here For

    Grounding the libido question in the closest available evidence, a review of GLP-1 effects on reward and motivation pathways, since no primary GLP-1/libido trial was found.

    Good For

    Understanding plausible mechanisms linking GLP-1 signaling to reward and motivation.

    Not For

    Direct evidence on libido specifically; this is indirect, mechanistic evidence, not a primary libido study.

    Physiology & Behavior 283:114622
    PMID 38945189